TGFB1 and pancreatic neoplasm: Pancreatic cancer cells with activated TGFβ induce angiogenesis when implanted into mice [121] whilst TGFβ-blocking antibodies or targeted deletion of TGFβ in mice results in decreased angiogenesis [122].